Andrew A. Hindman, Chief Business Development Officer at ACORDA THERAPEUTICS INC (ACOR), sold 7,704 shares at $15.75 ($121K) on 2017-05-15, disclosed to the SEC on 2017-05-17.
Seasonal sale ($121k) by Chief Business Development Officer — this insider has traded ACOR in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-05-30 | $2.1M | — | Filing → |
| ACOR | SELL | 2017-12-05 | $17K | — | Filing → |
| ACOR | SELL | 2016-12-05 | $9K | — | Filing → |